At Sterling Analytics, we understand the critical challenges and urgency that come with rare disease research. With fewer than 200,000 Americans affected by each condition, rare diseases demand specialized statistical strategies that maximize small datasets, support innovative trial designs, and meet stringent regulatory requirements.

Our rare disease expertise includes adaptive and Bayesian design approaches, integrated biomarker strategies, and collaborative engagement with patient advocacy groups and registries.

With every trial, Sterling Analytics delivers precision analytics to power rare disease innovation—turning small data into meaningful breakthroughs for underserved populations.